The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer‐specific survival

To investigate the effect of intraductal carcinoma of the prostate (IDC‐P) in radical prostatectomy (RP) specimens in the context of the site of recurrence, time to recurrence, and cancer‐specific survival in two academic cohorts of locally, regionally, or distantly recurrent prostate cancer.

[1]  Esther I Verhoef,et al.  Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy , 2016, Modern Pathology.

[2]  F. Montorsi,et al.  Impact of stage migration and practice changes on high‐risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades , 2016, BJU international.

[3]  D. Berney,et al.  Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists , 2016, Journal of Clinical Pathology.

[4]  Naoto Sassa,et al.  The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation , 2016, Modern Pathology.

[5]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[6]  L. Kunju,et al.  Intraductal Carcinoma of the Prostate: Morphologic Features, Differential Diagnoses, Significance, and Reporting Practices. , 2015, Archives of pathology & laboratory medicine.

[7]  Ewout W Steyerberg,et al.  Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer , 2015, Modern Pathology.

[8]  C. Sweeney,et al.  Management of Metastatic Hormone-Sensitive Prostate Cancer , 2015, Current Urology Reports.

[9]  Jiyan Liu,et al.  Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer? , 2015, The Prostate.

[10]  N. Willich,et al.  Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. , 2014, European urology.

[11]  T. H. van der Kwast,et al.  Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort. , 2014, European journal of cancer.

[12]  T. Tsuzuki,et al.  Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens , 2014, The Prostate.

[13]  Ming Zhou,et al.  Intraductal Carcinoma of Prostate: A Comprehensive and Concise Review , 2013, Korean journal of pathology.

[14]  T. H. van der Kwast,et al.  Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer? , 2013, The Prostate.

[15]  L. Collette,et al.  Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) , 2012, The Lancet.

[16]  R. Shah,et al.  Atypical Cribriform Lesions of the Prostate: Clinical Significance, Differential Diagnosis and Current Concept of Intraductal Carcinoma of the Prostate , 2012, Advances in anatomic pathology.

[17]  T. H. van der Kwast,et al.  Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. , 2012, European journal of cancer.

[18]  A. Partin,et al.  Evolution of the clinical presentation of men undergoing radical prostatectomy for high‐risk prostate cancer , 2012, BJU international.

[19]  C. Magi-Galluzzi,et al.  Intraductal carcinoma of the prostate. , 2012, Archives of pathology & laboratory medicine.

[20]  J. Epstein,et al.  Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. , 2010, The Journal of urology.

[21]  A. Renshaw,et al.  Protocol for the examination of specimens from patients with carcinoma of the prostate gland. , 2009, Archives of pathology & laboratory medicine.

[22]  E. Messing,et al.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.

[23]  A. Evans,et al.  Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications , 2009, Journal of Clinical Pathology.

[24]  Christopher Otis,et al.  Recommendations for the reporting of prostate carcinoma. , 2007, Virchows Archiv : an international journal of pathology.

[25]  Jonathan I. Epstein,et al.  Recommendations for the reporting of prostate carcinoma , 2007, Virchows Archiv.

[26]  J. Epstein,et al.  Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance , 2006, Modern Pathology.

[27]  P. Scardino,et al.  Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. , 1998, Human pathology.

[28]  M. Rubin,et al.  Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. , 1998, The American journal of surgical pathology.